KEPPRA 250 MG TABLET
FDA nonproprietary name: levetiracetam
For 30 tablets
Pharmacies pay
$242.36 filed
30 × $8.07857 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$283.71 estimated
$242.36 + $36.35 (15%) + $5.00 fee per fill = $283.71
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
KEPPRA 250 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as levetiracetam, under the trade name “Keppra”.
FDA gives its dosage form as tablet, film coated and its route as oral.
The labeler, the company named on the label, is UCB, Inc.
FDA lists no Established Pharmacologic Class for it.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 50474-0594-40.
NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $242.36 for 30 tablets (30 × $8.07857 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $0.05618 per EA filed.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What NADAC measures · Why 30 tablets · NADAC explanation codes
The NDC
- 50474-0594-40 · UCB, Inc. · $8.07857 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
17 other products in the NADAC file share the FDA nonproprietary name levetiracetam with KEPPRA 250 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| KEPPRA 1,000 MG TABLET | $19.8712 per EA filed | We don’t know yet |
| KEPPRA 100 MG/ML ORAL SOLN | $1.91893 per ML filed | We don’t know yet |
| KEPPRA 250 MG TABLET this page | $8.07857 per EA filed | We don’t know yet |
| KEPPRA 500 MG TABLET | $9.91702 per EA filed | We don’t know yet |
| KEPPRA 750 MG TABLET | $13.46136 per EA filed | We don’t know yet |
| KEPPRA XR 500 MG TABLET | $9.0242 per EA filed | $10.37505 per EA filed |
| KEPPRA XR 750 MG TABLET | $13.48131 per EA filed | $10.37505 per EA filed |
| LEVETIRACETAM 1,000 MG TABLET | $0.15968 per EA filed | $0.26202 per EA filed |
| LEVETIRACETAM 100 MG/ML SOLN | $0.03015 per ML filed | We don’t know yet |
| LEVETIRACETAM 250 MG TABLET | $0.05618 per EA filed | $0.26202 per EA filed |
| LEVETIRACETAM 500 MG TABLET | $0.07362 per EA filed | $0.26202 per EA filed |
| LEVETIRACETAM 750 MG TABLET | $0.10924 per EA filed | $0.26202 per EA filed |
| LEVETIRACETAM ER 500 MG TABLET | $0.17377 per EA filed | $0.52537 per EA filed |
| LEVETIRACETAM ER 750 MG TABLET | $0.22338 per EA filed | $0.52537 per EA filed |
| ROWEEPRA 500 MG TABLET | $0.07362 per EA filed | We don’t know yet |
| SPRITAM 1,000 MG TABLET | $10.199 per EA filed | $10.47293 per EA filed |
| SPRITAM 250 MG TABLET | $10.27223 per EA filed | $10.47293 per EA filed |
| SPRITAM 500 MG TABLET | $10.2412 per EA filed | $10.47293 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2025-12-17 and 2026-09-23 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- Is a generic version available, and would it suit me? NADAC lists a generic with the same ingredient, strength and dosage form by FDA: LEVETIRACETAM 250 MG TABLET. Ask your pharmacist or prescriber; do not switch on your own.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.